Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Tuberculosis

Free Subscription Articles published in Lancet Retrieve available abstracts of 33 articles: HTML format

Single Articles

August 2025
1. DROBNIEWSKI F, Kon OM, Gonzalo X, Ashmi M, et al
   Why are we failing to rapidly diagnose tuberculosis in the UK?
   Lancet. 2025;406:908-909.
   PubMed    
   
   
   July 2025
2. MACIEL EL, Pablos-Mendez A, Abubakar I
   Undoing progress through sudden tuberculosis funding cuts.
   Lancet. 2025 Jul 3:S0140-6736(25)01328-5. doi: 10.1016/S0140-6736(25)01328.
   PubMed    
   
   
   
3. HALLETT TB, Menzies NA, Resch S, Pretorius C, et al
   The case for optimal investment in combating HIV, tuberculosis, and malaria: a global modelling study.
   Lancet. 2025 Jul 3:S0140-6736(25)00831-1. doi: 10.1016/S0140-6736(25)00831.
   PubMed     Abstract available
   
   
   June 2025
4. AL ZAMEL AM, Saeed AA, Elmubarak M, Alsarraj MA, et al
   Sudan's tuberculosis response needs global support amid conflict.
   Lancet. 2025 Jun 2:S0140-6736(25)01119-5. doi: 10.1016/S0140-6736(25)01119.
   PubMed    
   
   
   April 2025
5. KLUGE HHP
   Tuberculosis: a threat to health security in the European region and the collective actions needed.
   Lancet. 2025 Apr 7:S0140-6736(25)00677-4. doi: 10.1016/S0140-6736(25)00677.
   PubMed    
   
   
   March 2025
6. DHEDA K, Perumal T, Fox GJ
   Asymptomatic tuberculosis: undetected and underestimated, but not unimportant.
   Lancet. 2025 Mar 21:S0140-6736(25)00555-0. doi: 10.1016/S0140-6736(25)00555.
   PubMed    
   
   
   
7. JERENE D, van Kalmthout K, Levy J, Alacapa J, et al
   Effect of digital adherence technologies on treatment outcomes in people with drug-susceptible tuberculosis: four pragmatic, cluster-randomised trials.
   Lancet. 2025 Mar 11:S0140-6736(24)02847-2. doi: 10.1016/S0140-6736(24)02847.
   PubMed     Abstract available
   
   
   
8. MARX FM, Civan A
   Rethinking the benefits of digital adherence technologies for tuberculosis treatment.
   Lancet. 2025 Mar 11:S0140-6736(25)00199-0. doi: 10.1016/S0140-6736(25)00199.
   PubMed    
   
   
   
9. TRAJMAN A, Campbell JR, Kunor T, Ruslami R, et al
   Tuberculosis.
   Lancet. 2025;405:850-866.
   PubMed     Abstract available
   
   
   February 2025
10. ZUMLA A, Sahu S, Yeboah-Manu D, Goletti D, et al
    Breaking dependency: strengthening the global tuberculosis response in the face of USAID cuts.
    Lancet. 2025 Feb 26:S0140-6736(25)00335-6. doi: 10.1016/S0140-6736(25)00335.
    PubMed    
    
    
    October 2024
11. BHARGAVA A, Bhargava M, Velayutham B, Benedetti A, et al
    Nutritional supplementation for tuberculosis prevention: the RATIONS trial - Authors' reply.
    Lancet. 2024;404:1524.
    PubMed    
    
    
    
12. ZHANG K, Xu Y, Hu Y, Chen X, et al
    Nutritional supplementation for tuberculosis prevention: the RATIONS trial.
    Lancet. 2024;404:1523-1524.
    PubMed    
    
    
    
13. BUSANG J, Khan P
    Nutritional supplementation for tuberculosis prevention: the RATIONS trial.
    Lancet. 2024;404:1522-1523.
    PubMed    
    
    
    
14. RICKMAN HM, Yates TA
    Nutritional supplementation for tuberculosis prevention: the RATIONS trial.
    Lancet. 2024;404:1522.
    PubMed    
    
    
    
15. KAUR JABINDA M
    Nutritional supplementation for tuberculosis prevention: the RATIONS trial.
    Lancet. 2024;404:1521-1522.
    PubMed    
    
    
    
16. BHATTARAI MD
    Utilising available isoniazid-resistance tests in new patients.
    Lancet. 2024;404:1403.
    PubMed    
    
    
    August 2024
17. KIZITO S, Nabayinda J, Nabunya P, Ssewamala FM, et al
    HIV and tuberculosis in Uganda: are we neglecting poverty?
    Lancet. 2024;404:844-845.
    PubMed    
    
    
    June 2024
18. HYDE L
    Mobile screening for Ukraine's wartime tuberculosis epidemic.
    Lancet. 2024;403:2771.
    PubMed    
    
    
    March 2024
19. BURKI T
    Pivotal tuberculosis vaccine trial begins.
    Lancet. 2024;403:1125.
    PubMed    
    
    
    
20. BHARGAVA A, Bhargava M, Pai M
    Tuberculosis: a biosocial problem that requires biosocial solutions.
    Lancet. 2024 Mar 20:S0140-6736(24)00489-6. doi: 10.1016/S0140-6736(24)00489.
    PubMed    
    
    
    
21. SUBBARAMAN R, Fielding K
    Putting technology to the test in tuberculosis care.
    Lancet. 2024;403:878-879.
    PubMed    
    
    
    January 2024
22. WEI X, Hicks JP, Zhang Z, Haldane V, et al
    Effectiveness of a comprehensive package based on electronic medication monitors at improving treatment outcomes among tuberculosis patients in Tibet: a multicentre randomised controlled trial.
    Lancet. 2024 Jan 31:S0140-6736(23)02270-5. doi: 10.1016/S0140-6736(23)02270.
    PubMed     Abstract available
    
    
    November 2023
23. SAMARASEKERA U
    Anurag and Madhavi Bhargava: enhancing TB prevention and care.
    Lancet. 2023;402:1740.
    PubMed    
    
    
    October 2023
24. BURKI T
    J&J patent decision to enable generic tuberculosis treatment.
    Lancet. 2023;402:1313.
    PubMed    
    
    
    September 2023
25. THE LANCET
    Tuberculosis: a different way of doing things.
    Lancet. 2023;402:937.
    PubMed    
    
    
    
26. REID M, Agbassi YJP, Arinaminpathy N, Bercasio A, et al
    Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis.
    Lancet. 2023 Sep 13:S0140-6736(23)01379-X. doi: 10.1016/S0140-6736(23)01379.
    PubMed    
    
    
    
27. BEKO B, Furin J
    Beyond individual inclusion, investment in affected communities is needed to end tuberculosis.
    Lancet. 2023 Sep 13:S0140-6736(23)01892-5. doi: 10.1016/S0140-6736(23)01892.
    PubMed    
    
    
    August 2023
28. BHARGAVA A, Bhargava M, Meher A, Benedetti A, et al
    Nutritional supplementation to prevent tuberculosis incidence in household contacts of patients with pulmonary tuberculosis in India (RATIONS): a field-based, open-label, cluster-randomised, controlled trial.
    Lancet. 2023 Aug 8:S0140-6736(23)01231-X. doi: 10.1016/S0140-6736(23)01231.
    PubMed     Abstract available
    
    
    
29. SINHA P, Mehta S
    Food: the tuberculosis vaccine we already have.
    Lancet. 2023 Aug 8:S0140-6736(23)01321-1. doi: 10.1016/S0140-6736(23)01321.
    PubMed    
    
    
    April 2023
30. REID M, Yamey G, Goosby E, Jamison D, et al
    Seizing opportunities to end TB: a call for ambition and optimism on World TB Day.
    Lancet. 2023;401:1153.
    PubMed    
    
    
    March 2023
31. KIRBY T
    Ruvandhi Nathavitharana: advancing TB diagnostics and advocacy.
    Lancet. 2023;401:990.
    PubMed    
    
    
    
32. KASAEVA T, Dias HM, Pai M
    Fast-tracking progress to End TB: high-level opportunities for investment and action.
    Lancet. 2023;401:975-978.
    PubMed    
    
    
    
33. WATTS G
    Bern-Thomas Nyang'wa: getting things done in TB and HIV.
    Lancet. 2023 Mar 17:S0140-6736(23)00576-7. doi: 10.1016/S0140-6736(23)00576.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.